Bioactis

Bio-Actis is a South Korean biotechnology company specializing in the research, development, and commercialization of microbiome-based therapeutics and high-functional probiotics. Founded in 1998, the company utilizes its proprietary microbial isolation and fermentation platform to develop a pipeline of live biotherapeutic products (LBPs) targeting a range of conditions, including atopic dermatitis, metabolic disorders, and liver disease. Bio-Actis is well-known for its commercial probiotic brands, such as Lactomin and Lactoclean, which are distributed globally through partnerships with major pharmaceutical companies like Sandoz. The company's R&D efforts are focused on the therapeutic modulation of the gut microbiome to address chronic inflammatory and immune-related pathologies. By combining traditional probiotic expertise with modern microbiome science, Bio-Actis aims to provide clinically validated solutions for global health challenges.